Ethereum treasury listed company Huajian Medical acquired Guofu Quantum's equity for 3.142 billion Hong Kong dollars to advance the RWA exchange strategy.

According to a report from 深潮 TechFlow on September 2, Hong Kong-listed Ethereum company Huajian Medical announced its acquisition of a 20.31% stake in Guofu Quantum for approximately HKD 3.142 billion to advance its RWA exchange strategy, with the transaction being paid for in the form of issued and allotted consideration shares at an issue price of HKD 9.69 per share. Upon completion of the acquisition, Huajian Medical will become the major shareholder of Guofu Quantum and will include it in its financial statements using the equity method. This acquisition is part of Huajian Medical's efforts to promote the RWA (Real World Asset) exchange strategy, creating a closed-loop ecosystem from the asset end to the trading end, and will lay out plans in the stablecoin market. In August this year, Huajian Medical announced the official launch of a global enhanced Ethereum treasury strategy with a downside protection mechanism, and will use Ethereum as the core reserve asset.